Development and Validation of Predictive Model-HASBLAD Score-For Major Adverse Cardiovascular Events During

Menglin Zhao1, Zhi Shang1, Jiageng Cai1

  • 1Department of Cardiology, Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.

Insights

New bedside tools, the nomogram and HASBLAD score, effectively predict major adverse cardiovascular events (MACEs) in Chinese patients undergoing non-cardiac surgery. These tools offer improved accuracy over existing methods for perioperative risk assessment.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Medical Informatics

Background:

  • Major adverse cardiovascular events (MACEs) are a leading cause of morbidity and mortality in the perioperative period of non-cardiac surgery.
  • Existing MACE prediction models lack validation in the Chinese population and are outdated for current clinical needs.
  • There is a critical need for accurate, accessible tools to predict MACEs in Chinese patients undergoing non-cardiac surgery.

Purpose of the Study:

  • To develop and validate simple bedside tools for predicting MACEs in Chinese patients during the perioperative period of non-cardiac surgery.
  • To establish a nomogram and a risk score for MACE prediction.
  • To compare the performance of the new tools against the Revised Cardiac Risk Index (RCRI).

Main Methods:

  • A nested case-control study design was employed.
  • Logistic regression analysis was used to develop a nomogram and a risk score (HASBLAD) based on seven predictors: Hemoglobin, CARDIAC diseases, AST, high Blood pressure, Leukocyte count, general Anesthesia, and Diabetes mellitus.
  • Internal validation was performed using a separate cohort to assess discrimination and calibration, comparing against the RCRI.

Main Results:

  • The nomogram and HASBLAD score demonstrated satisfactory prediction performance in both training and validation sets (C-statistics 0.781/0.768 and 0.865/0.843, respectively).
  • Both models showed good calibration for predicting MACE probability.
  • The nomogram and HASBLAD score exhibited superior discrimination compared to the RCRI in the validation set (P < 0.05).

Conclusions:

  • The developed nomogram and HASBLAD score are effective bedside tools for predicting perioperative MACEs in Chinese patients undergoing non-cardiac surgery.
  • These tools offer improved accuracy and clinical utility compared to the current RCRI.
  • Implementation of these tools can aid in better risk stratification and patient management.
Abstract

Related Concept Videos